NEW YORK (TheStreet) -- Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.
The stock was up 12.12% to $4.07 at 3:08 p.m. More than 1 million shares had changed hands, compared to the average volume of 270,889.
Must Read: Warren Buffett's 25 Favorite Stocks
